Science in Sport Share Forecast, Price & News

GBX 80.22
-0.78 (-0.96 %)
(As of 06/17/2021 04:07 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume194,615 shs
Average Volume351,506 shs
Market Capitalization£108.38 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SIS News and Ratings via Email

Sign-up to receive the latest news and ratings for Science in Sport and its competitors with MarketBeat's FREE daily newsletter.

About Science in Sport

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, and sports and fitness enthusiasts. The company offers energy bars, gels, powders, and shots; hydration products; recovery products; protein products; supplements; and vitamins and minerals. It sells its products under the PhD Nutrition and Science in Sport brand names through various retail channels, including traditional and online supermarkets and high street chains; specialist sports retailers; e-commerce sites; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as through its websites in the United Kingdom, rest of Europe, Australia, and internationally. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.41 out of 5 stars

Analyst Opinion: 2.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Science in Sport (LON:SIS) Frequently Asked Questions

Is Science in Sport a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Science in Sport in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Science in Sport stock.
View analyst ratings for Science in Sport
or view top-rated stocks.

What stocks does MarketBeat like better than Science in Sport?

Wall Street analysts have given Science in Sport a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Science in Sport wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Science in Sport's earnings last quarter?

Science in Sport plc (LON:SIS) released its quarterly earnings data on Wednesday, September, 16th. The company reported ($1.80) earnings per share (EPS) for the quarter.
View Science in Sport's earnings history

How has Science in Sport's stock been impacted by COVID-19?

Science in Sport's stock was trading at GBX 41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SIS shares have increased by 95.7% and is now trading at GBX 80.22.
View which stocks have been most impacted by COVID-19

What price target have analysts set for SIS?

1 equities research analysts have issued 1 year price targets for Science in Sport's shares. Their forecasts range from GBX 100 to GBX 100. On average, they expect Science in Sport's stock price to reach GBX 100 in the next twelve months. This suggests a possible upside of 24.7% from the stock's current price.
View analysts' price targets for Science in Sport
or view top-rated stocks among Wall Street analysts.

Who are Science in Sport's key executives?

Science in Sport's management team includes the following people:
  • Mr. Stephen N. Moon, CEO & Exec. Director
  • Mr. James Lonsdale Simpson, CFO & Exec. Director (Age 47, Pay $174k)
  • Mr. Ashley Read, Chief Operating Officer
  • Muna Khan, Chief Technology Officer

Who are some of Science in Sport's key competitors?

What other stocks do shareholders of Science in Sport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Science in Sport investors own include Cidara Therapeutics (CDTX), Carnival Co. & (CCL), Bellway (BWY), British American Tobacco (BTI), boohoo group (BOO), B&M European Value Retail (BME), Balfour Beatty (BBY), Alibaba Group (BABA), Advanced Oncotherapy (AVO) and ASOS (ASC).

What is Science in Sport's stock symbol?

Science in Sport trades on the London Stock Exchange (LON) under the ticker symbol "SIS."

How do I buy shares of Science in Sport?

Shares of SIS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Science in Sport's stock price today?

One share of SIS stock can currently be purchased for approximately GBX 80.22.

How much money does Science in Sport make?

Science in Sport has a market capitalization of £108.38 million and generates £50.35 million in revenue each year.

How many employees does Science in Sport have?

Science in Sport employs 176 workers across the globe.

What is Science in Sport's official website?

The official website for Science in Sport is www.scienceinsport.com.

Where are Science in Sport's headquarters?

Science in Sport is headquartered at 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom.

How can I contact Science in Sport?

Science in Sport's mailing address is 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom. The company can be reached via phone at +44-1282-440980.

This page was last updated on 6/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.